Company Update

Bacil Pharma has filed a certificate confirming its share dematerialization processes for the quarter ending June 30. The company's Registrar and Transfer Agent verified that all shares submitted for dematerialization were processed correctly.

This includes ensuring dematerialized shares are listed, original physical certificates are cancelled, and depositories are recorded as the new owners within the specified timeframe.

This filing highlights the company's commitment to maintaining accurate shareholder records and efficient share transfer operations.